Virica Biotech Introduces Viric.AI™, an Active Learning Platform to Accelerate Biomanufacturing Optimization

Virica Biotech, an Ottawa-based company focused on improving biomanufacturing through its Viral Sensitizers (VSE™) enhancer technology, recently announced the launch of Viric.AI™, a proprietary active learning platform that accelerates the discovery of optimized biomanufacturing enhancers, as part of their service offering to clients. Given the complexity of biomanufacturing processes, Viric.AI™ will enable their partners to move faster and make better decisions whether they’re working in viral vectors or other advanced biologics systems.

Virica Biotech is an alumnus of our BDSP™ and WiHI programs, and presented at the OBIO® Investment Summit.

Next
Next

Yellowbird Diagnostics Announces First Patients Dosed in Phase 1 Trial of NeuCaVis™